Insightec has submitted a Pre-Market Approval (PMA) to the Japanese Pharmaceuticals and Medical Devices Agency (PMDA) for its Exablate NeuroTM (Exablate 4000) device for treating advanced Parkinson’s Disease patients suffering from mobility, rigidity or dyskinesia effects.

HAIFA, Israel – May 14th, 2018 – Insightec®, a global medical technology innovator of incisionless surgery, today announced that it has submitted a Pre-Market Approval (PMA) to the Japanese Pharmaceuticals and Medical Devices Agency (PMDA) for its Exablate NeuroTM (Exablate 4000) device for treating advanced Parkinson’s Disease patients suffering from mobility, rigidity or dyskinesia effects.

The Exablate Neuro, which uses focused ultrasound together with MR imaging to treat deep within the brain with no incisions, is intended to improve motor function and reduce dyskinesia. Dyskinesia is one of the debilitating symptoms that presents as uncontrolled, involuntary movement of the arms and/or legs. Dyskinesia often occurs as a side effect of medication in Parkinson’s Disease patients.

“Insightec is committed to supporting research that extends the applications and potential of focused ultrasound, to improve the lives of people living with Parkinson’s disease with a much less invasive approach than conventional surgery,” commented Maurice R. Ferré MD, Insightec’s CEO and Chairman of the Board of Directors.

The Exablate Neuro is currently approved by MHLW to treat medication-refractory essential tremor. There are currently seven medical institutions in Japan performing the incisionless focused ultrasound treatment for essential tremor on a routine basis.

About Insightec

Insightec is a global medical technology innovator transforming patient lives through incisionless brain surgery with MR-guided focused ultrasound. Research for future applications in the neuroscience space is underway in partnership with leading academic and medical institutions. Insightec is headquartered in Haifa, Israel, and Miami, with offices in Dallas, Tokyo and Shanghai.

For more information, please visit: www.insightec.com

admin

Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry’s standard dummy text ever since the 1500s, when an unknown printer took a galley of type and scrambled it to make a type specimen book. It has survived not only five centuries, but also the leap into electronic typesetting, remaining essentially unchanged. It was popularised in the 1960s with the release of Letraset sheets containing Lorem Ipsum passages, and more recently with desktop publishing software like Aldus PageMaker including versions of Lorem Ipsum.

A Better Tomorrow
Starts Here

Discover the transformative power of Incisionless Focused Ultrasound.

Start a Transformation
Start A Transformation
Font Resize